We saw the stock market experience its weakest week in 6 months. Since the start of September, the S&P 500 is down 5% and the tech-heavy Nasdaq has plunged 9%. Meanwhile, one sector of the market is still crushing it: the IPO market.
IPOs – or initial public offerings – are when companies list on public exchanges. And according to Bloomberg, it’s the hottest sector in the market. That’s why earlier this week, Daily editor Teeka Tiwari held his first-ever Set for Life Summit to tell ordinary investors how they can get into this red-hot market.
Teeka says the gains that can truly set you up for life can be found in a particular niche of the IPO market: biotech. Venture capitalist (VC) investment is accelerating at an unprecedented pace in this sector.
For instance, on Wednesday night, Teeka reported VCs had invested $5.5 billion in biotech companies that had IPOs this year. But new reports show they’ve increased that spending to a record $6.7 billion. That’s $1.2 billion in the blink of an eye.
This past week, we’ve shown you why VCs are piling into biotech. You can get the rundown below or watch Teeka’s presentation on this red-hot trend right here…
|
|
|
|
|
Regards,
Chaka Ferguson
Managing Editor, Palm Beach Daily
P.S. During his presentation, Teeka revealed the details of a pre-IPO biotech company that he believes can return 30x. This idea is more urgent than you may think.
You see, pre-IPO deals have strict limits on how much capital they can raise. And the space on this deal is filling up quickly.
He can’t promise it’ll be open past today. So click here now to learn more…